|
Exhibit 10.3
Employment Agreement
This Employment Agreement
(“ Agreement ”), dated as of June, 1, 2008,
is entered into between China Biologic Products, Inc., a company
established in the United States with its principal office
located at No. 14., East Hushan Road, Taian City, Shandong, PRC
(“Company”), and Yu-Yun Tristan Kuo (the “
Executive ”).
WHEREAS, the Company desires to
engage the Executive as, and the Executive agrees to serve as,
Chief Financial Officer of the Company, upon the terms and
conditions contained herein.
NOW THEREFORE, for good and
valuable consideration, the sufficiency of which is hereby
acknowledged by the parties, the parties hereto hereby agree as
follows:
1.
EFFECTIVENESS OF AGREEMENT AND
EFFECTIVE DATE
This Agreement will become
effective as of the date hereof. For the purpose of this
Agreement, the term “Effective Date” means June 1,
2008.
2.
EMPLOYMENT AND
DUTIES
2.1
General . The Executive will perform such duties and services for
the Company as may be designated from time to time by the Board
of Directors of the Company (the “ Board ”)
or the Chief Executive Officer of the Company. The Executive
agrees to serve the Company faithfully and to the best of his
ability under the direction of the Board and the Chief Executive
Officer of the Company and to carry out the functions typically
performed by a Chief Financial Officer, including but not
limited to responsibility for (i) all financial management and
accounting for the Company, (ii) compliance with local GAAP
principles (and in a form that can be converted into US GAAP)
and all applicable regulatory authorities, and (iii) supervising
the Company’s compliance with its SEC reporting
obligations, its internal controls and other corporate
governance obligations, the Sarbanes-Oxley Act and other
applicable securities laws. The Executive and the Company
further agree that the Executive is also serving as the Chief
Financial Officer of Shandong Taibang Biological Products Co.,
Ltd. (“Shandong Taibang”) the Company’s
primary operating subsidiary that a
substantial portion of the CFO’s time and attention will
be devoted to the business and affairs of Shandong Taibang and
the Company’s other subsidiary companies (collectively the
“Subsidiaries”), that such time and attention to the
business and affairs of the Subsidiaries is for the benefit of
the Company and in furtherance of the Executive’s duties
and responsibilities to the Company under this Agreement and
applicable law, and that the CFO will not be required to
allocate any fixed minimum amount of time to any one entity
during any one time period, although is expected and required to
devote substantially all of his time and attention during normal
business hours to the affairs of the Company and/or the
Subsidiaries.
1
2.2
Term of Employment
. The Executive’s employment under this
Agreement will commence as of the date hereof and will
terminate on the first year of the Effective Date; provided,
however , that the term of the Executive’s employment
will be automatically extended without further action of either
party for additional one (1) year periods unless written notice
of either party’s intention not to extend has been given
to the other party hereto at least thirty (30) days prior to the
expiration of the then effective term (the initial term and any
extensions thereof, the “ Term of Employment
”). Notwithstanding the foregoing, the Executive’s
employment may be terminated during the Term of Employment as
provided in Section 5 below.
2.3
Reimbursement of
Expenses . Unless otherwise agreed to
by the Executive and the Company, the Company will reimburse the
Executive for reasonable travel and other business expenses
incurred by him to fulfill his duties hereunder upon
presentation by the Executive of an itemized account of such
expenditures, in accordance with Company practices consistently
applied.
3.
COMPENSATION
3.1
Base Salary
. From the Effective Date, the Executive will be
entitled to receive a base salary (“ Base Salary
“) at a rate of ¥1,320,000 per annum (to be paid in
Executive’s personal accounts), payable in accordance with
the Company’s payroll practices and applicable law.
If the rate of Base Salary per annum paid to Executive is
increased during the Term of Employment, such increased rate
will thereafter constitute the Base Salary for all purposes of
this Agreement. Base Salary will not be decreased during
the Term of Employment without the mutual consent of Executive
and the Company.
3.2
Annual Review
. The Executive’s Base Salary will be
reviewed by the Board, based upon the Executive’s
performance not less than annually.
3.3
Bonus Compensation
. In addition to his Base Salary, Executive
shall be eligible to receive an annual cash performance bonus
(the “Bonus”) for each calendar year during the Term
of Employment in an amount equivalent to one month’s Base
Salary if, and to the extent that, Executive remains employed by
the Company on December 15th of such calendar year. Such Bonus
shall be paid no later than January 15 th of the
calendar year following the year in which the Bonus is earned.
Executive further may be eligible receive additional bonus
compensation as may be awarded to the Executive from time to
time by the Board in the sole and absolute discretion of the
Board.
2
3.4
Additional
Compensation .
3.4.1
Initial Stock
Option . Subject to approval by the
Board of Directors (or an appropriate Committee appointed by
such Board of Directors), on or before June 1, 2008, Executive
will be granted an option (the “Initial Option”) to
purchase 75,000 shares of the Company’s common stock (the
“Shares”) under the Company’s 2008 Equity
Incentive Plan (the “Plan”). The Initial
Option will be evidenced by a Stock Option Agreement as
contemplated by the Plan, both of which will govern the Initial
Option, notwithstanding any other provision of this Agreement.
The exercise price of the Initial Option will be $4.00 per
share; provided, however, that if the fair market value of the
Shares as of the grant date is greater than $4.00 per share,
then the exercise price of the Initial Option will be the fair
market value as of the grant date. The Initial Option will
vest in accordance with the provisions of the Stock Option
Agreement.
3.4.2
Bonus Upon PIPE
Financing . Upon completion of each
PIPE financing by the Company (or within one (1) month following
the closing of each such financing) and, provided Executive
remains employed by the Company on the date of the closing of
each such financing, Executive shall receive a cash bonus
equivalent to one percent (1%) of the gross proceeds raised via
such financing (“Cash Bonus”); provided, however,
that if the Company does not complete the first PIPE financing
before 12/31/2008, the Executive will not be entitled to any
Cash Bonus upon the Company’s completion of its first PIPE
financing following 12/31/2008 (but will be eligible to receive
the Cash Bonus upon completion by the Company of subsequent PIPE
financing as long as he remains employed by the Company on the
date of the closing of such subsequent PIPE financing). In
lieu of the cash bonus described above, the Executive may elect
to receive an equivalent number of shares of the Company’s
common stock at no cost to him.
3.4.3
Stock Option Upon Listing on
NASDAQ/NYSE/AMX . Upon the
Company’s listing on NASDAQ, NYSE or AMX (or within one
(1) month following such listing), and provided Executive
remains employed by the Company on the date of such listing,
Executive shall receive an option (“Listing Option”)
to purchase 50,000 shares of the Company’s common stock
pursuant to the Company’s Plan. The exercise price
of the Listing Option shall be the fair market value as of the
date of the grant. The Listing Option shall be immediately
vested and exercisable on the date of the grant. The
Listing Option will be evidenced by a Stock Option Agreement as
contemplated by the Plan, both of which will govern the Listing
Option, notwithstanding any other provision of this Agreement.
3
3.4.4
Executive will be eligible to
participate in any employment compensation plan established by
the Company under the same terms as other Company executives and
at levels recommended by the CEO of the Company and approved by
the Board of Directors.
3.5
Taxes . The Company shall be responsible for the employer’s
share of taxes as required by United States laws and regulations
and the Executive shall be responsible for payment of any
personal income or other taxes in the PRC and the United States;
provided, however, that if the Company requires the Executive to
travel within the United States for more than thirty-five (35)
days during any period of twelve (12) consecutive months and, as
a result solely of such required travel within the United
States, the Executive is unable to claim the foreign earned
income exclusion on his United States tax return, the Company
shall reimburse the Executive, on a fully grossed-up basis, for
any such net United States income taxes, in excess of foreign
tax credits, that Executive is required to pay.
4.
EMPLOYEE
BENEFITS
4.1
Leave . The Executive will be entitled to accrue 15 working
days paid annual leave each calendar year (which will not be
carried over in the event that they are not used by the
Executive). All annual leave days will be taken at times
mutually agreed by the Executive and the Company and will be
subject to the business needs of the Company. If, however,
in any calendar year during the Term of Employment, the
Executive is unable to take any annual leave due to the business
needs of the Company, the Company, in its discretion, shall
either pay the Executive the equivalent of 15 working days, or
permit the Executive to carry such leave over into the following
calendar year.
4.2
Medical Coverage.
The Company will either (a) purchase and provide
Executive and his spouse with reasonable medical health
insurance that provides coverage both within and outside the PRC
or (b) reimburse the Executive for the premiums he incurs for
purchasing such medical health insurance for himself and his
spouse.
4.3
Home Trip Allowance
. After b
|